Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
U.K.
Biotech
Geopolitics ‘chills’ British biotech IPO plans, despite VC boost
Geopolitical uncertainty has continued to “chill” IPO sentiment for British biotechs, an industry leader told Fierce, even as VC funding ramped up.
James Waldron
Jul 20, 2026 7:45am
Fierce Biotech heading to UK amid London Life Sciences Week
Jun 11, 2026 4:57am
UK invests $64M to expand trials to underserved communities
Mar 4, 2026 10:51am
Cornerstone secures $200M to take its surgical robot global
Nov 18, 2025 9:45am
Hookipa walks back Poolbeg purchase plan
Feb 20, 2025 1:34pm
UK regulator looks to halve approval times for low-risk trials
Oct 12, 2023 7:05am
